Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,376
Total Claims
$483K
Drug Cost
288
Beneficiaries
$1,678
Cost/Patient
Risk Score Breakdown 8/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-90%
Opioid rate vs peers
0.9% vs 9.2% avg
+133%
Cost per patient vs peers
$1,678 vs $719 avg
+153%
Brand preference vs peers
16.8% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.9%
Opioid Rate
32
Opioid Claims
$143
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 564 claims · $434K
Generic: 2,790 claims · $49K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 94 | $101K |
| Tirzepatide | 51 | $74K |
| Fluticasone/Umeclidin/Vilanter | 22 | $25K |
| Dapagliflozin Propanediol | 18 | $17K |
| Apixaban | 15 | $17K |
| Dulaglutide | 13 | $14K |
| Mirabegron | 13 | $8,354 |
| Budesonide/Formoterol Fumarate | 15 | $7,802 |
| Insulin Degludec | 13 | $4,764 |
| Albuterol Sulfate | 85 | $2,051 |
| Levothyroxine Sodium | 125 | $1,931 |
| Atorvastatin Calcium | 160 | $1,903 |
| Sertraline Hcl | 38 | $1,783 |
| Olmesartan Medoxomil | 20 | $1,679 |
| Ezetimibe | 17 | $1,561 |
Prescribing Profile
Patient Profile
70
Avg Age
63%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About